BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ag490

alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide [Supplementary Concept] Heading Mapped to: Tyrphostins

14+ PubMed studies analyzed · Evidence Score: 26.5

Research Domains

Ag490 has been studied across 8 research domains including 🔬 Inflammation, 🔬 Oncology, 🛡️ Immunity, 🫘 Kidney, 🧠 Focus & Attention. The primary research focus is 🔬 Inflammation with 43% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ag490, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

triolimus
10 shared targets
deguelin
8 shared targets
daph
8 shared targets
Thapsigargin
7 shared targets
monorden
7 shared targets
piceatannol
16 shared targets
KN
6 shared targets
Idarubicin
11 shared targets
Nitroprusside
5 shared targets
Dibucaine
7 shared targets
Loading evidence profile...

This evidence profile for Ag490 is generated deterministically from 14 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.